The C-terminus Hsp70 interacting protein (CHIP) has dual function as both co-chaperone and ubiquitin ligase. CHIP is increasingly implicated in the biology of polyglutamine expansion disorders, Parkinson's disease and tau protein in Alzheimer's disease. We investigated the involvement of CHIP in the metabolism of the b-amyloid precursor protein and its derivative b-amyloid (Ab). Using immunoprecipitation, fluorescence localization and crosslinking methods, endogenous CHIP and bAPP interact in brain and cultured skeletal myotubes as well as when they are expressed in stable HEK cell lines. Their interaction is confined to Golgi and ER compartments. In the presence of the proteasome inhibitor with MG132, endogenous and expressed bAPP levels are significantly increased and accordingly, the interaction with CHIP enhanced. Concurrently, levels of Hsp70 were most consistently induced by proteasome inhibition among the various heat shock proteins (HSPs) tested. Thus, complexes of CHIP, Hsp70 and holo-bAPP (as well as C-terminal fragments) were stabilized by the action of MG132. Moreover, CHIP itself is shown to both increase cellular holo-bAPP levels and protect it from oxidative stress and degradation. Interestingly, CHIP also promotes the association of ubiquitin with bAPP, implying that a smaller pool of bAPP is destined for proteasomal processing. In neuronal cultures, CHIP and Hsp70/90 expression reduce steady-state cellular Ab levels and hasten its degradation in pulse-chase experiments. The functional significance of CHIP and HSP interactions, especially with Hsp70, was tested using siRNA and in neuronal cells where protection from Ab-induced toxicity is shown. We conclude that CHIP, as a bimolecular switch, interacts with HSP to stabilize normal holo-bAPP on the one hand while also assisting in the ubiquitination of a subpopulation of bAPP molecules that are destined for proteasome degradation. CHIP also hastens the clearance of Ab in a manner consistent with its known neuroprotective properties.
INTRODUCTION
A large body of evidence supports the hypothesis that the accumulation of intracellular Ab42 is an early event in the pathogenic cascade of Alzheimer's disease, resulting in neuronal dysfunction, synaptic/neuronal loss and clinical dementia (1 -9) . Several recent studies have suggested that certain molecular chaperones, heat shock proteins (HSPs) Hsp70 and Hsp90 and co-chaperones, e.g. C-terminus of Hsp70 interacting protein (CHIP), assume important roles in maintaining protein homeostasis in a crowded cytoplasmic milieu. These act to lessen the toxicity of misfolded and aggregated proteins in polyglutamine expansion disorders and other neurodegenerative conditions (10 -13) . Previously, we have reported that Hsp70 participates in the neuroprotective response to the expression and accumulation of intracellular b-amyloid (14, 15) . To better understand the roles of molecular chaperones in the biochemical events associated with b-amyloid-induced neurodegeneration, we have examined the function and interactions of the Hsp70 client protein, CHIP.
CHIP is a ubiquitously expressed cytoplasmic protein that is structurally conserved across multiple species and is highly expressed in brain, heart and muscles (16) . The Nterminal region of CHIP has three tetratricopeptide repeat domains, which are responsible for protein -protein interactions with HSPs 70/90 and other molecular chaperones including Hip, Hop, Cyclophilin 40, FKBP52 and Bag1 phosphatase 5 (17 -20) . The CHIP C-terminus contains a U-box, or RING finger-like domain, which is the site of its ubiquitin (UBQ) E3 ligase activity (21) . Owing to these dual capacities, CHIP acts as a molecular triage center (22) linking the chaperones to the UBQ proteasome system. CHIP is a critical switch that controls protein fate by orchestrating attempts at re-folding versus degrading misfolded proteins (23, 24) .
Recent studies have implicated CHIP and its UBQ ligase activity in interactions with proteins harboring expanded polyglutamine tracts by targeting them for degradation in the proteasomal system (13, 25) . Thus, CHIP is co-immunoprecipitated with huntingtin and ataxin-3, whereas overexpression of CHIP leads to increased ubiquitination and degradation of both mutant polyQ-modified proteins (25) . A wider role for CHIP in other neurodegenerative conditions has been suggested from studies implicating it in familial Parkinson's disease, where it has been found to assist in the dissociation of Hsp70 from a complex with Parkin and PAEL-R, facilitating Parkin-mediated PAEL-R ubiquitination (26) . CHIP appears to mediate, at least in part, the degradation of a-synuclein by triaging between the proteasomal and lysosomal pathways (27) . CHIP also targets the immature CFTR protein for proteasomal degradation (28, 29) . Recently, a possible role for CHIP in the cellular response to tau-protein stress has been uncovered, where it was shown to polyubiquitinate phosphorylated 4-repeat-tau, attenuate tau aggregation and enhance cell survival (30 -32) .
In addition to these associations, CHIP induces trimerization of the transcription factor HSF1, leading to the activation of HSP genes and induction of a protective program against apoptosis and cellular stress (33, 34) . The multifunctional CHIP also influences Hsp70 levels by an additional mechanism that is independent of HSF1 transcriptional activation and opposite in effect (35) . This showed that CHIP not only enhances Hsp70 induction during acute stress but it also mediates the turnover of Hsp70 during stress recovery. The biphasic regulation of Hsp70 highlights the existence of a competition between Hsp70 and other substrates for CHIP's ubiquitination action. CHIP appears to sense stress protein levels in its decision to terminate Hsp70 action. Thus when CHIP molecules are involved in the modification and targeting of a misfolded protein for degradation, Hsp70 levels are induced. When the substrate is eventually returned to a normal conformation or levels of its denatured form are eliminated, CHIP then functions to degrade its partner (35) . In so doing, basal levels of Hsp70 are re-established.
In the present investigation, by studying the interactions between CHIP, HSPs and the b-amyloid precursor protein (bAPP), we hypothesized that CHIP may have a more universal range of substrates with respect to neurodegenerative proteins. Our investigations examined this question in both endogenous and cell culture overexpression models. We indeed find that these three proteins interact natively and that this interaction is enhanced in the presence of proteasomal inhibition. Laser scanning confocal microscopy was used to probe the subcellular regions of interaction. The colocalization results implicate the ER and Golgi compartments. Interestingly, overexpression of CHIP appears to stabilize steady-state holo-bAPP levels, in part through changes in the rate of bAPP maturation and degradation. On the other hand, CHIP also promotes the association of some bAPP with ubiquitin (UBQ), presumably in preparation for degradation. Moreover, CHIP, in complex with several HSPs, is part of a machinery that attenuates Ab 42 peptide levels in both SH-SY5Y neuroblastoma cells and in cultures of primary cortical neurons. These results suggest that CHIP has dual roles with contrasting effects on bAPP metabolism: as co-chaperone to induce proper folding and lessen degradation of holo-APP and as probable intermediate to another E3 ligase that ubiquitinates bAPP. In addition to these, CHIP appears to hasten the degradation of b-amyloid, an undesirable bAPP metabolite. A switch-like property between these bifunctional activities is consistent with CHIP action on other substrates.
RESULTS
Identification of CHIP -APP and APP -UBQ complexes: stabilization with inhibition of the proteasome Our previous finding of chaperone induction, specifically Hsp70, in a cell culture model of Alzheimer's disease-type cellular stress (15) led us to investigate the possibility of interaction between the Hsp70 client protein CHIP and holo-bAPP or with products of b and b/g-secretase action on bAPP, C99 and Ab, respectively. Since the C-terminal, cytoplasmic region of bAPP has been shown to undergo ubiquitination (36, 37) and the co-chaperone/UBQ ligase CHIP, together with Hsp70 and the other molecular chaperones, functions to triage proteins destined for correct folding or UBQ-proteasome-dependent degradation, we studied the effect of proteasome inhibition, using MG132 on CHIP -APP -HSP complex formation and on the levels of the individual components. Our initial experiments utilized differentiated mouse C2C12 myotubes, an abundant source of endogenous bAPP (38) . Later experiments confirmed those results in an HEK cell line that overexpresses bAPP.
In Figure 1A (top), western analysis reveals that proteasomal inhibition using MG132 leads to an increase in steady-state, endogenous bAPP levels in C2C12 myotubes and a minor change in basal CHIP. Lactacystin treatment led to the same result (not shown). We next used immunoprecipitation (IP) followed by western blot to determine whether an interaction between bAPP and CHIP could be demonstrated. IP of CHIP from myotube extracts led to the pulldown of bAPP and vice versa, an effect that was enhanced in the presence of proteasomal inhibition (Fig. 1A, middle Human Molecular Genetics, 2007, Vol. 16, No. 7 849 Figure 1 . Interaction of holo-bAPP and CHIP in both endogenous and overexpression systems. (A) Upper panel: Western blot analysis for endogenous expression levels of both APP and CHIP in whole-cell lysates from C2C12 myotubes cultured in the presence (þ) or absence (2) of proteasome inhibitor MG132 and fractionated on 8% polyacrylamide gel. cdk4 was used as a control for loading. IPs using either anti-CHIP (middle) or anti-bAPP (lower) followed by western blot reveal an interaction between APP and CHIP, which is enhanced in the presence of the proteasome inhibitor MG132. Non-immune IgG was used as a control for specificity. (B) Extracts of human brain tissue were used for western blot analysis, IP and inverse IP, as described in (A). bAPP expression was detected using both anti-C8 and anti-22C11 antibodies. CHIP expression was detected using rabbit polyclonal anti-CHIP, whereas anti-actin served as a loading control. Duplicate IPs followed by western blot with either anti-CHIP or anti-APP identify the presence of the CHIP-APP complex in human brain. (C) Stable APP751-HEK cells were transiently transfected with WT-or DUBL-CHIP in the presence or absence of MG132. Top three panels denote input and IPs using anti-myc epitope antibody (for CHIP) followed by western blot for bAPP. MG132 enhances the association of APP with both WT and the mutant DUBL-CHIP. Lanes 1 and 2 show a common non-specific reaction using this antibody to myc. Middle two and lower two panels: IP with anti-UBQ followed by APP western blot and inverse IP with anti-APP followed by UBQ immuno blot identify full-length APP in weak association with UBQ (lane 1). The association is greatly increased in the presence of exogenous WT (lanes 3 and 4) but not mutant CHIP (lane 5) as well as generally by inhibition of the proteasome (lanes 2, 4 and 6). Stripping and re-probing of these blots with anti-UBQ do not identify any overall alteration in ubiquitinated proteins under the different conditions. Proteasome inhibition and/or WT CHIP expression is shown to enhance APP expression in the stably transfected cell line (bottom panel) as it with endogenous level (C2C12 myotubes and SHSY5Y cells). (D) Control IPs using anti-CHIP do not show interaction with either calnexin or the insulin receptor (alpha) subunit.
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Human Molecular Genetics, 2007, Vol. 16, No. 7 and lower panel). This interaction appears to not be limited to muscle because we used the same methodology to identify complex formation between CHIP and APP in samples prepared from human brains (Fig. 1B) . This interaction was further probed in a stably transfected HEK293 cell line expressing wild-type (WT) human APP751 (APP751-HEK). Transient transfection of these cells with myc-tagged CHIP expression constructs demonstrates again the interaction between CHIP and APP (Fig. 1C, panel 2, lane 3) . We additionally found that the use of a mutant CHIP, lacking its U-box ligase domain, was still capable of interacting with APP in a proteasome sensitive manner (lane 5). Importantly, CHIP expression and proteasome inhibition each appears to raise holo-bAPP in whole-cell extracts (lanes 2 -4 versus 1, see also panel 6 below). APP751-HEK cells were used next to determine whether CHIP expression and complex formation with APP have the expected effect to promote either the association of UBQ with APP or the direct UBQ modification of bAPP. In Figure 1C (28) and ataxin-3 (25) . Proteasome inhibition, as anticipated, floods the cells with UBQ (panel 5) and drives many UBQ reactions (e.g. panels 4, 5 and 6; lane 6). The specificity of the CHIP -APP interaction was supported by the absence of the association between CHIP and either calnexin or the a -subunit of the insulin receptor (Fig. 1D ). Both control proteins are endoplasmic reticulum (ER) residents.
Functional aspects of CHIP -APP complex formation
In order to test whether APP engages with endogenous CHIP, form complexes in the stable APP751-HEK cells, we used a thiol cleavable, homobifunctional crosslinking reagent with a 12 Å spacer in cell extracts. In Figure 2A , two high molecular weight signals of 150 and 190 kDa were detected, which were immunoreactive to the anti-APP or anti-CHIP (brackets). Since the same signals disappear under reducing conditions, it is possible that they correspond to complexes of APP with one (maximum two) CHIP molecule plus a variable contribution from Hsp70. Next, we asked whether the APP subpopulation bound to CHIP is itself ubiquitinated. The logic follows from CHIP having intrinsic E3 ligase activity, in addition to its major chaperone function, and Figure 1C demonstration that whole-cell APP is associated with or directly modified by UBQ in the presence of CHIP. In Figure 2B , top panel, APP is pulled down with UBQ in the presence of CHIP (lane 3) or MG132 (lane 2), consistent with Figure 1C , panel 6 results. However, as shown in Figure 2B, Figure 2C and D IP experiments, drastic declines in CHIP or Hsp70 are shown to greatly diminish CHIP -APP and APPHsp70 as well as Hsp70 -APP and APP -CHIP interactions, respectively.
Subcellular colocalization of bAPP 751 and CHIP
Previous studies have shown that CHIP interacts with other proteins in the region of the ER (25, 26, 28) and that while found in the cytosol, it can localize to the nucleus during stressful stimuli (34) . We utilized laser confocal microscopy to examine the distribution of both bAPP and CHIP in APP751-HEK cells. Cells were co-transfected with myctagged CHIP and expression plasmids for fluorescent protein constructs specifically targeting subcellular domains including the ER (pECFP-ER), Golgi complex (pECFP-golgi) and mitochondria (pEYFP-mito) (See Materials and Methods). Initial experiments aimed at localizing APP and CHIP produced a largely vesicular pattern of fluorescence with some perinuclear architecture (Fig. 3A) . Using the specifically targeted compartment markers, we were able to co-localize the signals for CHIP and bAPP in the region of the ER and Golgi, but not in the mitochondria (Fig. 3B , C and D).
Proteasome inhibition enhances steady-state levels of APP and Hsp70
Environmental and misfolded protein stress in the cytosol triggers expression of the heat shock response, involving the induction of HSPs. HSPs are molecular chaperones that together with co-chaperones such as CHIP can stabilize or triage proteins for proteasomal degradation. Thus, degradation of fatally damaged proteins can be blocked by proteasome inhibition (39) . By western blot analysis, we examined the impact of proteasomal inhibition and CHIP overexpression on HSP levels in APP751-HEK cells. MG132-treated cells showed a 2 -3-fold increase in steady-state APP and Hsp70, as well as Hsp60 ( Interactions between holo-bAPP, CHIP and selected molecular chaperones
Previous studies have shown that the ER-associated chaperone Bip/Grp78 (a member of the Hsp70 chaperone family) interacts with bAPP to facilitate its correct folding and metabolism (2) . We next investigated whether the bAPP and CHIP interaction incorporated several HSPs and whether they were differentially sensitive to MG132 treatment. Using lysates prepared from the APP751-HEK cell line, we find that stress induced by proteasomal inhibition leads to an increased association not only between CHIP and bAPP (as noted earlier), but also between CHIP and Hsp70 ( Fig. 5A) . A lesser change, but in the same direction, is noted in the interaction of CHIP/APP and Hsp60, following proteasome inhibition. These interactions are also identified when each of the inverse IP are performed (Fig. 5B ). Hsp90 levels and associations did not appear to change much in this experimental paradigm. The association with Hsp60, considered a mitochondrial chaperone, is somewhat surprising. However, when checked ( Figure 5C ), significant levels of this protein were found present in the cytosol.
CHIP affects bAPP metabolism and associates with secretase products of its proteolysis
In order to understand what effect CHIP -APP interactions may have on holo-bAPP metabolism, we used a pulse-chase labeling paradigm. APP751-HEK cells were transfected with either a WT CHIP or a control GFP construct. After pulse labeling with a mixture of 35 S-methionine and cysteine, cells were chased for times up to 120 min. Extracts from each time point were immunoprecipitated with a rabbit polyclonal antibody directed against the extreme C-terminus of APP. The presence of transfected CHIP appears to stabilize Figure 6B . CTFs in this molecular range are produced by the action of b-and a-secretases on APP to yield C99 and C83 amino acid species (12 -10 kDa), respectively. As expected, in the presence of MG132, there is accumulation of both CTFs, which shows further stabilization in cells that co-express CHIP (Fig. 6B) . In order to determine whether these proteolytic products of APP also associate with CHIP and/or HSPs, we utilized IP assays (Fig. 6C ). Extracts were prepared from APP751-HEK cells transfected with CHIP, treated with MG132, or both. First, IP with anti-CHIP, -Hsp60, -Hsp70 or -Hsp90, followed by western development with an antibody directed against APP, confirms an association between all of these molecules. However, only CHIP -APP and Hsp70 -or Hsp60 -APP interactions are enhanced, following proteasomal inhibition (Fig. 6C, upper panel) . In Figure 6C , lower panel, it is shown that an interaction between the CTF C99, the precursor to Ab, and Hsp70 is slightly stronger than with the others. The specificity is determined by detection with both anti-C8 (recognizing all CTFs, upper panel) and antibody 6E10 (recognizing the Ab1 -17 epitope within C99, lower panel). This association is brought out only in the presence of CHIP with MG132. Interestingly, although Hsp90 is also pulled down with bAPP (Figs 5B, bottom, and 6C, far right), it is not involved with CTFs. These results identify differential associations between CHIP, certain HSPs and bAPP, and that proteolytic products of bAPP are also detected in the complex but only if stabilized by proteasome inhibitors.
In its role of co-chaperone, CHIP is expected to stabilize proteins when faced with oxidative stress and potential irreversible damage. We tested this in cell culture exposed to hydrogen peroxide (H 2 O 2 ). In Figure 6D , increasing doses of H 2 O 2 resulted in declining levels of bAPP. The overexpression of CHIP (þ) significantly interrupted degradation of bAPP, as predicted.
CHIP and HSP interactions with Ab 1 -42
The results so far show involvement of CHIP in the stabilization of holo-bAPP and implicate CHIP in the proteasome-sensitive disposition of secretase products of bAPP proteolysis. Hsp70 features prominently in both the processes. We next tested the hypothesis that CHIP and HSPs might also influence the levels and stability of the b-amyloid peptide. For these experiments, we utilized the human neuroblastoma cell line SH-SY5Y and a doxycycline-inducible adenoviral construct encoding Ab 1 -42 . The latter is targeted for processing through the ER-Golgi system (14) . Cultures were individually infected with adenoviral (Ad) constructs encoding CHIP, Hsp60, Hsp70 or Hsp90 and 24 h post-infection were co-infected with AdTREAb 1 -42 ; 24 h after this second infection, Ab expression was induced by the addition of 1 mg/ml of doxycycline for 24 h. In the presence of Ad-CHIP expression, the accumulation of intracellular Ab is substantially reduced compared with control (Fig. 7A, lane 4 versus 6 ). Extending this analysis to the HSPs, we found that there was a differential impact of HSP overexpression on the accumulation of Ab 42 . In Figure 7B , Hsp70 expression is shown to reduce accumulation of Ab 42 (lane 4 versus 2), whereas Hsp60 had no effect (lane 6) (40) . Interestingly, Hsp90 showed the greatest impact on Ab 42 reduction (lane 8). The latter is an unexpected finding since Hsp90 is neither sensitive to proteasome inhibition nor associated with APP CTFs. The data from three additional independent experiments confirm these effects on Ab-levels (Fig. 7B, chart) .
These data raise the question of whether or not changes to Ab levels are reflected in any way by the association of the same chaperones with the Ab molecule. To address this, we immunoprecipitated each chaperone before probing western blots with anti-Ab 6E10. Indeed, as shown in Figure 7C , Ab is pulled down with endogenous Hsp70 (lane 2). Moreover, overexpression of Hsp70, by driving down total Ab-levels (Fig. 7B) , is correspondingly associated with lesser amounts (lane 4). Similarly, IP of endogenous CHIP yielded Ab, and CHIP overexpression in turn was associated with a further reduction in attached Ab (Fig. 7D) . Endogenous Hsp90 is also avidly associated with Ab. When overexpressed, Hsp90 similarly pulled down less Ab (Fig. 7E) , explained by its superior ability to lessen the total cellular load of Ab (Fig. 7B) . The importance of CHIP and HSP chaperone interactions with Ab in a cellular context is emphasized in Figure 7F . Quantitative IP of Ab from media and whole-cell lysates clearly demonstrates preponderance of intracellular over extracellular Ab species in all the cell lines (see legend). Therefore, these chaperones display a variable capacity for interaction with and reduction of Ab 42 load, which is only partially reflected in their interactions with APP CTFs and, in the case of CHIP, in their effects on APP metabolism.
CHIP accelerates Ab 1 -42 removal and protects against toxicity
The interaction of CHIP with APP and between CHIP and Ab, taken with the CHIP-regulated reduction in steady-state Ab levels, suggest that CHIP may (i) promote secretory processing and protease degradation or affect transcription control of bAPP, (ii) impose a block on b-and g-secretase actions or (iii) hasten Ab clearance. The first two possibilities are unlikely given the results presented thus far. Using a pulse-chase labeling paradigm, we then examined the degradation of Ab in the stable APP751-HEK cell line in the presence and absence of added WT CHIP. Extracts were immunoprecipitated using antibody R1282 against Ab 1 -42 at varying times of chase (Fig. 8A) . In the presence of exogenous CHIP, we have found that the rate of intracellular Ab degradation is enhanced (Fig. 8A, graph) . We next examined the functional effects of CHIP and HSPs on cell viability under stress from Ab accumulation. SH-SY5Y cells were infected with various adenoviral constructs, as described previously. For all of the chaperones tested, there was a protective effect (60 -80% increase) on cell viability as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) reduction levels (Fig. 8B) . The combination of Hsp70 and CHIP was noticeably cooperative in this respect. We extended these findings to cultures of mouse primary cortical neurons, where CHIP (or Hsp70, not shown) increased the survival of cells challenged by Ab accumulation. A corresponding decrease in the Human Molecular Genetics, 2007, Vol. 16 , No. 7 In the presence of MG132 treatment, levels of CTFs are increased, an effect that is further enhanced by CHIP overexpression. (C) IPs above and immunoblots to the left as indicated were used to explore APP and CTF's interactions using proteasome inhibition, or both are shown to enable detection of APP CTF interactions using antibodies C8 and 6E10. CHIP, Hsp60 and Hsp70, but not Hsp90, associate with both the C99 and C83 APP-CTFs as detected by antibody C8. The identity of C99 is verified by stripping and re-probing with antibody 6E10. (D) APP751-HEK cells were transfected with WT CHIP or empty vector and subjected to oxidative stress using increasing doses of hydrogen peroxide for 1.5 h. Whole-cell lysates were probed by western blot for anti-APP, anti-CHIP and anti-actin. CHIP increases the reduction in steady state of APP levels, caused by increasing H 2 O 2 concentration.
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Human Molecular Genetics, 2007, Vol. 16, No. 7 detectable levels of Ab peptide is shown beneath Figure 8C . Hsp90 resulted in a similar reduction in levels of endogenous Ab in primary cortical neurons, whereas Hsp60 did not (not shown), consistent with the SH-SY5Y cell results presented in Figure 7B . These data demonstrate that manipulation of UBQ ligases and/or the expressions of their molecular chaperones may provide cells with a strategy to combat cellular stress associated with b-amyloid accumulation. SH-SY5Y and myotubes were infected with the adenovirus-encoding b-amyloid and induced in the presence of doxycycline. Equivalent amounts of whole-cell extract (100 mg) and the total media (35 mm dish, 1 ml) of the infected and uninfected APP751-HEK cells were used for IP by R1282 (for Ab), followed by immunoblot using antibody 6E10 as probe. The very last lane corresponds to a synthetic peptide control added to sample buffer.
DISCUSSION
Several studies have highlighted the close association between molecular chaperones, co-chaperones and the UBQproteasomal degradation pathway to influence the handling of misfolded, unfolded or aggregated proteins (41 -43) . CHIP is one such co-chaperone, which is endowed with dual properties and sensor function to switch between protein stabilization and degradation pathways. Thus, CHIP acts as a co-chaperone regulating correct folding (16) and as an E3 
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Human Molecular Genetics, 2007, Vol. 16, No. 7 UBQ ligase (21, 44) . Owing to this contrasting bifunctionality, CHIP appears to triage protein fate between the chaperone and proteasome systems (22 -24) . Although CHIP has been suggested to play a widespread role in protein handling among polyglutamine disorders, Parkinson's disease and tauopathies (13, 25, (30) (31) (32) , there is no previous description of any contribution to APP biology. In the present study, we have presented data that support a direct interaction between WT holo-bAPP and CHIP. IP and western blot interaction studies were performed in several endogenous expression systems. In C2C12 myotubes, for example, using a native CHIP antibody, it is shown that SDS-stable CHIP -APP complexes are readily pulled down. Although CHIP levels themselves do not greatly change, levels of normal APP, a potential client protein, are greatly stabilized in the presence of proteasomal inhibition and the amount of precipitable complex increases proportionately (Fig. 1A) . In the overexpression system (stable APP751-HEK), IP/WB experiments also reveal that CHIP is interacting with both N-and N þ -O-linked glycosylated APP isoforms. Moreover, APP/ endogenous CHIP complexes are captured in the absence of MG132 using a protein crosslinker. The expected engagement of UBQ in the APP -CHIP complexes is shown in several ways. First, APP -UBQ interactions are stabilized under proteasome blockade. Secondly, APP -UBQ associations are also increased when WT CHIP is overexpressed. Thirdly, a mutant CHIP lacking the RING-finger containing UBQ ligase domain (DUBL) does not result in the ubiquitination of APP. Next, we show that the APP directly attached to CHIP is not itself ubiquitinated, suggesting another E3 ligase is subsequently involved in APP ubiquitination. Finally, APP/CHIP complex formation is reduced when CHIP or Hsp70 are knocked down. Importantly, these interactions are not limited to cell culture systems, as we have found evidence for molecular association between CHIP and bAPP in samples prepared from post-mortem human brain. Our model of CHIP's bifunctional triage action is illustrated in Figure 9 . In summary, CHIP may switch roles to (i) stabilize normal APP levels or (ii) act as an intermediate in the ubiquitination of an unwanted, smaller pool of APP (probably targeted to the proteasome) and additionally to (iii) reduce levels of cytotoxic b-amyloid. The functional significance of CHIP as chaperone to stabilize APP during oxidative stress is demonstrated in Figure 6D .
Previous studies by Nunan et al. (36, 37) found that Cterminal fragments of APP generated by b-secretase action (e.g. APP -CTFb or C99) are ubiquitinated and subjected to cleavage in a proteasome dependent manner. Little else is known of holo-bAPP metabolism by the proteasome, whereas Ab peptides are stabilized by proteasome inhibition (45, 46) . On the contrary, more is known about bAPP movement through the secretory pathway, endosomal recycling, secretase processing and lysosomal degradation (47 -54) . In support of chaperone-mediated APP processing, Yang et al. (2) found that APP and the ER stress response chaperone Bip/Grp78 interact to facilitate the correct folding of nascent APP. They also demonstrated that APP underwent b/g secretase processing in the ER/Golgi complex and that Bip/Grp78 overexpression resulted in reductions of soluble APP, CTFs and Ab peptides. The combined published UBQ-proteasome and chaperone data suggested that bAPP biology, folding and degradation might also be subject to the regulation by a bifunctional co-chaperone/UBQ ligase such as CHIP. Here, we have shown that CHIP, along with the chaperones Hsp60, 70 and 90 not only interact with but also influence the metabolism of holo-bAPP.
The results from pulse-chase experiments suggest that although CHIP may stabilize APP for up to 90 min into the chase, it is thereafter processed at a rate comparable with that observed under control conditions. We note that degradation rates of a-synuclein in the presence and absence of CHIP also become similar (27) . This is consistent with the stabilization or maintenance of steady-state levels of WT APP in the presence of CHIP ( Figs 1C, 4A and 6B ). Further evidence for involvement of CHIP and the proteasome system in APP handling comes from our finding that in addition to CHIP -APP complex formation, Hsp70 -APP and CHIP -Hsp70 interactions are specifically stabilized in the absence of proteasome function (Fig. 5A and B) . Interestingly, CHIP also influences APP C-terminus fragment levels and is itself bound to them, an effect made detectible when the proteasome is blocked. As these fragments include the b-secretase-generated C99 fragment (the immediate precursor to Ab), especially as shown in Hsp70 pull-downs in Figure 6C , it suggested that molecular co-chaperones, such as CHIP, might also influence the accumulation of the b-amyloid peptide product of subsequent g-secretase action on C99.
Although the pull-down data show CHIP, APP and the HSPs co-exist in a soluble complex (Fig. 5A) , their relative stoichiometry and strength of binding remain to be determined. The 150 and 190 kDa crosslinked complexes of Figure 2A could indicate that CHIP -APP may either interact directly and independent of HSP or be tethered by a bridging chaperone, i.e. Hsp70 in 1:1:1 molar ratio. We favor an interdependent trimolecular arrangement because the siRNA data show that the Figure 9 . A model of CHIP in the biology of b-APP homeostasis. CHIP is endowed with bifunctional properties as a molecular chaperone (top) and as an intermediate to another UBQ E3 ligase (bottom). CHIP may stabilize, protect or re-fold either normal or salvageable holo-APP in most circumstances (strong arrow). However, where some APP is destined for destruction or in case of b-amyloid accumulation (light and broken arrow), CHIP will assist in APP ubiquitination or other pre-degradation reactions. Another E3 ligase is presumed to take over the direct ubiquitination reaction after CHIP.
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APP -Hsp70 partnership depends on CHIP as much as APP -CHIP depends on Hsp70 (Fig. 2C and D) . Owing to the fact that HSP/CHIP interacts with APP -C99 CTF (Fig. 6C ) and the Ab peptide ( Fig. 7C and D) , it is tempting to speculate that binding to holo-APP involves the intact Ab domain. Future interaction experiments with various deletion constructs will address this question. The selective complex formation between CHIP and APP, which exhibits protesome dependence and involves Hsp70 over the other HSPs, is additional evidence in favor of a specific role of CHIP in APP processing. We previously have shown that Hsp70 is upregulated as part of the stress response to intracellular Ab accumulation in cultured neurons (14, 15) . In this context, it is important to note that yet another role of CHIP is to activate HSF-1, which positively controls the expression of Hsp70 (34, 35) . In our study, Hsp70 (and Hsp60) levels are also induced, although modestly in the presence of exogenous CHIP (Fig. 4A) . Conversely, CHIP controls Hsp70 levels by orchestrating its proteolytic destruction once the misfolded or unfolded protein substrate is disposed of or refolded ('stress recovery' or 'sensor switch function') (35) . Indeed, Hsp70 protein levels were the most responsive to MG132-mediated proteasome inhibition and more so with added CHIP (Figs 4 and 5) . Levels of Hsp70 transcripts also become elevated after proteasome blockade (Fig. 4B) . The proteasome inhibitor MG132 is a peptide aldehyde that accelerates the transcription of HSPs and other ER chaperones. Thus, under proteasome blockade, intracellular protein breakdown is inhibited by 70%, triggering the expression of heat shock genes, or components of the proteolytic pathway such as polyubiquitin (39) . Our data in Figures  1C and 4 are consistent with this. The precise steps in the degradation of the proteasome-sensitive pool of bAPP and in the subsequent termination of Hsp70 levels that are orchestrated by CHIP, if resembling the model of protein stress (35) , remain to be investigated. Whether APP and Hsp70 compete in anyway for CHIP function and confirmation that CHIP does not itself directly ubiquitinate APP are also questions for future study.
We report for the first time that there additionally exists an interaction between CHIP and other HSPs, with the more toxic APP byproduct, the Ab 1 -42 peptide. We also show here that CHIP, Hsp70 and Hsp90 attenuate the accumulation of Ab 1 -42. The relationship between the interaction of CHIP with b-APP and additional capacity to depress steady-state Ab levels (Fig. 7A) is not explained by an inhibition of or sequestration of APP from secretase processing. First, CHIP expression increases rather than decreases the appearance of the MG132-stabilized C-terminal fragments ( Fig. 6B and C) . Secondly, pulse-chase results suggest that CHIP promotes Ab degradation (Fig. 8A) . We found that Hsp70 expression equally degrades steady-state Ab levels (Fig. 7B) , an effect probably related to its strong interaction with CHIP and APP, as shown in Figure 5A and B, respectively, under proteasome blockade.
Not all the HSPs act similarly in our CHIP/APP/Ab paradigm. Although, Hsp90 is also a CHIP client chaperone (Fig. 5 ), it appears not subject to the same proteasome regulation and APP binding, as are Hsp70 and, to a lesser extent, Hsp60, in various cell types (Figs 4 and 5A and B) . We speculate this might be related to its association with an even greater reduction in Ab levels and decreased affinity for the APP-CTFs. CHIP as mentioned, hastens the proteasome-dependent degradation of Hsp70 when stress protein levels fall below a threshold (35) . Whether Hsp90 escapes such controls remains to be found. As shown in Figure 7 , all the HSPs tested interact with Ab. Moreover, the ratio of associated Ab to HSPs decreases in most cases as the individual HSP levels are increased, as expected. The exception, Hsp60, does not affect Ab levels to the degree the others do [ Fig. 7B and (40)] but is nevertheless highly protective via an alternative mitochondrial mechanism [ Fig. 8B and (40)]. Although Hsp70 is closely linked to CHIP and proteasome clearance, the Hsp90 and Hsp60 results highlight the probability that differential chaperone mechanisms exist for the regulation of Ab.
The functional consequence of CHIP and HSP action to depress Ab levels on cell viability was demonstrated in two neuronal culture systems and by two assays: either CHIP or Hsp70 alone and synergistically, protected SH-SY5Y cells from intracellular Ab stress. In primary neurons, Hsp70 (and Hsp90) or CHIP expressions also rescued cells from Ab toxicity in step with reductions in Ab levels (Fig. 8) . Increasing evidence supports the hypothesis that many neurodegenerative conditions have in common cellular stress associated with protein misfolding, differential partitioning and/or aggregation. Here we found that the bifunctional co-chaperone/E3 UBQ ligase CHIP, in association with molecular chaperones, especially Hsp70, affects the biology of a new client substrate, bAPP, and concurrently enhances the removal of its toxic proteolytic product. Another neurodegeneration-linked protein, phospho-tau, is a client substrate for CHIP. Similar to our data on APP, the protein tau, CHIP and HSPs are in complex together. The resulting direct ubiquitination of tau is also enhanced in the presence of MG132 (12, 31, 32, 55) . In the APP instance, the difference is that CHIP probably acts as the intermediate before the transfer to another ligase for direct ubiquitination.
It is curious that CHIP has not been reported in yeast two hybrid screening assays using bAPP as bait. Further studies will address whether this interaction preferentially takes place in insoluble or inaccessible compartments. Any role of Parkin in the bAPP -CHIP interaction also needs to be clarified in future research. In this light, CHIP may conceivably pass APP (or Ab) onto Parkin, much like the PAEL-R substrate (26, 56) , or have no relation to Parkin as in the case with tau (12, 32) .
MATERIALS AND METHODS

Constructs and reagents
Plasmids encoding full-length, myc-epitope-tagged WT CHIP in pcDNA3.1 (GenBank TM accession CHIP IMAGE clone ID: 3847704 ATCC) and various deletion mutants in the U-box region were generated as described (57) . HEK293 cells stably transfected with human APP751 (APP751-HEK) were cultured in the presence of G418, as described previously (58) . Adenoviral constructs for Hsp60, Hsp70 and Hsp90 were as described previously (59) . Adenoviral construct for Transient and siRNA transfection All cell lines were transiently transfected using a calcium phosphate precipitation method (2M CaCl 2 , DNA and water plus 2Â HBS). Cells were treated 48 h after transfection with either 30 mM MG132 or Lactacystin for an additional 12 h. APP751-HEK stably cells were transfected with either CHIP SiRNA (Santa Cruz) or Hsp70 SiRNA, as described previously (15) . Cell lysates were used for western blot analysis and for IP experiment.
Protein crosslinking experiment A crosslinker agent 3,3 0 -dithiobissulfosuccinimidyl propionate (DTSSP) was used as per the manufacturer's protocol (Pierce, Rockford, IL, USA). Cell lysates (100 mg) from APP751-HEK stable cells were exposed to a molar excess of DTSSP or solvent. The mixture was incubated on ice for 2 h after which the reaction was quenched with 50 mM Tris, pH7.5, for 15 min on ice. Samples were mixed with 2Â SDS sample buffer with or without b-mercaptoethanol (b-ME) and resolved on 6% SDS -PAGE, transferred, incubated with appropriate antibodies and the signals visualized using enhanced chemiluminescence reagents and film from GE Healthcare (Piscataway, NJ, USA).
Mitochondrial and cytosolic fractionation We used a method to isolate the mitochondrial and cytosolic fraction from cell lines, as described previously (40) . Cells were suspended in ice-cold sucrose -mannitol buffer, followed by homogenization in a Dounce homogenizer. Homogenates were centrifuged at 600g for 5 min at 48C. The supernatant containing the mitochondria was saved, and the procedure repeated on the pellet. The pooled supernatant was centrifuged at 16 000Âg for 10 min at 48C. The new pellet containing the mitochondria was resuspended in 100 ml isolation buffer (Pierce Biotechnology). The supernatant is the cytosolic compartment.
Infection of primary cortical neurons and SH SY5Y cells with adenovirus Low passage SH-SY5Y cells were grown to 70 -80% confluence in DMEM containing 10% FBS, penicillinstreptomycin, 1 mM pyruvate and 2 mM glutamine. Primary cortical neurons were isolated and cultured in Neurobasal medium plus B27 supplements (Invitrogen), as previously described (14) . Unless otherwise indicated, cells were first infected for 24 h with Ad-CHIP, AdHsp60, AdHsp70 or AdHsp90 constructs (50 -100 m.o.i.) and then subjected to a second infection for an additional 24 h with AdTet-On and AdTRE-Ab42 (1:5 ratio). Ab expression was induced by the addition of doxycycline at 1 mg/ml for a further 24 h.
Immunoprecipitations
Cells were lysed in Triton lysis buffer containing Tris-HCl (pH 7.4, 20 mM), NaCl (150 mM), Na 4 P 2 O 7 (10 mM), Na 3 VO 4 (2 mM), protease inhibitor cocktail (Complete; Roche Biochemicals, Indianapolis, IN, USA), phenylmethylsulfonyl fluoride (44 mg/ml), and Triton X-100 (1% vol/vol), incubated on ice for 10 min, and then centrifuged at 10 000g for 10 min. The whole-cell extract supernatants were used directly for western blot analysis (20 mg of total protein) or for IP. IPs were performed using 100 -300 mg of extract protein. Following a preclearing incubation with protein A/G-Sepharose (Sigma, St Louis, MO), extracts were incubated for 3 -4 h at 48C with 3 mg of primary antibody, followed by the addition of Protein A/G Sepharose and an additional incubation at 48C for 1 h. Immunoprecipitates were harvested by centrifugation at 14 000g for 5 min at 48C and washed several times in 48C 1Â phosphate buffered saline (PBS) buffer containing protease inhibitor cocktail (Roche Biochemical) and PMSF before elution and electrophoresis.
Western blot analysis
Protein (20 mg) from Triton-soluble cell extracts or immunoprecipitates were heated (958C, 10 min) in Laemmli sample buffer, cleared by centrifugation, separated on SDS -PAGE and then blotted onto PVDF membrane (Immobilon-P; Millipore, Bedford, MA, USA). Membranes were blocked using TBS containing 5% (wt/vol) non-fat dry milk. After incubation with primary antibodies (1:500 -1000 dilution) in the same buffer for 18 h at 48C, blots were washed, incubated in HRP-conjugated secondary antibodies (1:2000 dilution; DAKO, Carpinteria, CA, USA), washed and the signals visualized using enhanced chemiluminescence reagents and film from GE Healthcare.
Confocal microscopy for colocalization
HEK293 cells were seeded on glass cover slips (9 Â 9 mm, coated with 0.1% gelatin) and transiently co-transfected with pCMV-APP 751 , WT CHIP and different cell compartment marker cDNAs (1 mg) described previously; 48 h after transfection, cells were fixed for 15 min at room temperature using 4% paraformaldehyde in PBS. After permeabilization and blocking, cells were incubated in primary antibody in PBS containing 0.4% BSA and 5% goat serum overnight at 48C. After washing, samples were incubated with goat-derived Human Molecular Genetics, 2007, Vol. 16, No. 7 861 secondary antibodies (1:200) labeled with Cy2 or Cy3 (Jackson Immuno Research, West Grove, PA, USA). After washing, the coverslips were mounted in DAKO-Fluoromount. Samples were examined using a Nikon C1 laser scanning confocal microscopy system in multi-tracking mode to eliminate signal bleed-through. All images were collected with a constant pinhole diameter at 40Â in order to maintain the depth of focus.
RNA isolation and RT -PCR
Total cellular RNA was isolated from cultured cells, using the RNeasy mini kit, following the manufacturer's instructions (QIAGEN, Valencia, CA, USA). RNA was eluted with diethylpyrocarbonate-treated water or TE. For the synthesis of cDNA, 1 mg of random hexanucleotides (GE Healthcare) were annealed to 1-3 mg RNA in a 20 ml reaction volume after heating for 5 min at 958C. The samples were transferred to room temperature and 30 ml of first-strand reverse transcriptase buffer containing 10 mM DTT, 2.4 mM dNTPs and 40 U/ reaction reverse transcriptase was added. The reactions were incubated for 1 h at 378C, followed by 7 min at 958C for denaturation of the DNA and enzyme. The samples were kept on ice or stored at 2208C. For the PCR reaction, 3 ml of singlestranded cDNA was amplified in a reaction containing 10 mM Tris -HCl, pH9.0, 1.5 mM MgCl 2 , 50 mM KCl, 10 pmol/ reaction reverse and forward primer, 0.2 mM dNTPs and 1 U/reaction Taq DNA polymerase in a final volume of 30 ml (cycle condition: 958C-5 minÂ1 cycle; 958C-1 min, 55 -658C-1.5 min. and 728C-1.5 min Â 25 cycles; 728C-7 minÂ1 cycle).
MTT cell viability assay
To measure cell viability, cells were washed twice in warm D-PBS and incubated in 1 ml DMEM containing 0.5 mg MTT (Molecular Probes, Eugene, OR, USA) for 2-3 h at 378C and 5% CO 2 . The medium was aspirated and the cells were washed twice with PBS at room temperature. Formazan salt was dissolved in 1 ml pure ethanol. Cells were homogenized by repetitive pipetting, followed by centrifugation for 5 min at 4500 r.p.m. (1700g) and the supernatant collected by careful decanting to avoid re-dissolving the protein pellet in ethanol. The absorbance was read against an ethanol blank at 564 nm in a PerSeptive CytoFluor4000 (ABI).
